Two years of wearing the Viaskin patch for peanut allergy desensitized 81 percent of peanut-allergic children ages 1 to 3,… Read more »
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
After three years of using the Viaskin Peanut patch in children ages 4 to 11, more than half (52 percent)… Read more »
DBV Technologies has announced that the FDA has agreed to review the company’s Viaskin Peanut patch for potential regulatory approval.… Read more »
The manufacturer of the Viaskin Peanut patch has announced plans to resubmit its biologics license application (BLA) for the therapy… Read more »
We’re learning more about the two therapies to treat peanut allergies that could soon be available in allergist’s offices in… Read more »
With a positive approach, our allergic child does not miss out. In fact, she’s even taking part in the science.
Meet the teenager impacting research as an intern and study participant.